39 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Recommendations for the Treatment ... Aspergillosis - IDSA Guidelines ... Aspergillosis #Treatment ... #pharmacology # ... medications #IDSA #Guidelines
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
the 3 main drug classes ... of these drug classes ... Guideline recommendations ... patients genotype, treatment ... #DAAs #Pharmacology
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... #Antibiotics #Treatment ... Regimen #Management #Guidelines ... #pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... LAMA #LABA #ICS #Guidelines
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... compared the study treatment ... with ‘treatment ... clinical practice guideline1 ... EBM #Management #Pharmacology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... HFrEF), we follow Guideline-Directed ... by the ACC/AHA guidelines ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... exacerbations. 2019 GOLD guidelines ... #Indications #Pharmacology
Paxlovid Drug-Drug Interactions
Before prescribing ritonavir-boosted nirmatrelvir (Paxlovid) for outpatient treatment of COVID-19, determine whether the patient
for outpatient treatment ... files.covid19treatmentguidelines.nih.gov/guidelines ... Interactions #DDI #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
duration same as for treatment ... Disease Note: Treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology